Your browser doesn't support javascript.
loading
Relationship between Antibody Levels and SARS-Cov-2 Reinfection.
Islamoglu, Mehmet Sami; Cengiz, Mahir; Uysal, Betul Borku; Ikitimur, Hande; Ozdemir, Zeynep; Karamehmetoglu, Ahsen; Akbulut, Ayse Ezgi; Bakdur, Ayse Nur; Ozdemir, Azize; Kayikcioglu, Habibe; Ozdemir, Hatice; Uces, Rumeysa; Ersoy, Sema; Yavuzer, Serap.
Afiliação
  • Islamoglu MS; Department of Internal Medicine, Istanbul, Turkey mislamoglu@biruni.edu.tr.
  • Cengiz M; Department of Internal Medicine, Istanbul, Turkey.
  • Uysal BB; Department of Internal Medicine, Istanbul, Turkey.
  • Ikitimur H; Department of Pulmonary Diseases, Istanbul, Turkey.
  • Ozdemir Z; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Karamehmetoglu A; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Akbulut AE; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Bakdur AN; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Ozdemir A; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Kayikcioglu H; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Ozdemir H; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Uces R; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Ersoy S; Department of Biruni University Medical Faculty Student Group, Istanbul, Turkey.
  • Yavuzer S; Department of Internal Medicine, Istanbul, Turkey.
Ann Clin Lab Sci ; 51(6): 750-755, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34921027
ABSTRACT

OBJECTIVE:

In this period when mutant strains are increasing all over the world, studies on how much humoral immunity will protect against the Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) are quite limited. The aim of our study is to investigate the positivity and antibody levels of the COVID-19 reverse transcription polymerase chain reaction (RT-PCR) test, the frequency of SARS-CoV-2 re-infection, and the protective antibody level against re-infection.

METHODS:

Patients who were positive for COVID-19 IgG antibody between 1 July and 31 August were included in our study. The COVID-19 RT-PCR test positivity, age, gender and comorbidities of these patients were recorded before this date. The COVID-19 RT-PCR test positivity of these patients was followed from the National COVID-19 Database between September 1, 2020 and February 28, 2021.

RESULTS:

1665 patients (female male 683 982, mean age 40.6±13.4 years). Among all patients, 14 patients had reinfection and the frequency of reinfection was 0.8%. It was observed that the frequency of reinfection was more frequent in patients with PCR negative (p<0.001). The IgG cut-off value causing reinfection was found to be 11.9 (AUC 0.844, 79.2% sensitivity, 78.6% specificity) (p<0.001).

CONCLUSION:

Humoral antibodies against SARS-CoV-2 were protective against COVID-19 reinfection, 0.8% of the patients had reinfection and the resultant reinfection was mostly seen in PCR negative patients who were asymptomatic.
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: Reinfecção / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Reinfecção / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article